NCT07070739View on ClinicalTrials.gov

A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease

PHASE2Not yet recruitingINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions

Bechet's Disease

Interventions

DRUG

HSK44459 tablets

Orally, twice a day

All Listed Sponsors

lead

Haisco Pharmaceutical Group Co., Ltd.

INDUSTRY